Liu Jiali, Wu Yan, Zhu Yuanying, Yu Cuicui, Zhang Ying, Luo Ting, Wei Juanna, Mu Hongjie, Xu Hui
School of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai 264005, China.
Research and Development Center, Yantai New Era Health Industry Co., Ltd., Yantai 265500.
Phytomedicine. 2024 Jan;122:155122. doi: 10.1016/j.phymed.2023.155122. Epub 2023 Oct 6.
Colchicine (COL) is a well-known plant-derived mitogenic toxin that has been widely applied for the treatment of immune system diseases and various cancers. However, its clinical use is severely limited by frequent occurrence of poisoning accidents, and the mechanism of COL poisoning is not clear yet.
The present study aimed to unveil how COL works as a toxin based on untargeted metabolomics analysis of animal models and clinical human case.
KM mice orally administered COL were used to establish poisoning models, and plasma samples were collected for untargeted metabolomics analysis. The data mining was performed to screen dose-dependent differences and disturbed metabolic pathways. The blood samples collected from clinical COL poisoning human case at various time points during treatment period were further analyzed to investigate the temporal changes in the metabolic disposition of COL in vivo and also verify the findings from mice. Finally, the expression of key pathways was evaluated by ELISA and Western blotting analysis.
Histological examination demonstrated systemic toxicity of COL poisoning in mice. Metabolite profiling analysis of plasma samples from model mice and clinical case both revealed that COL poisoning could significantly disturb in vivo metabolism of amino acid and lipid metabolism by the FXR/AMPK signal pathway. Quantitative monitoring of the metabolic process of COL further demonstrated that it could be greatly ameliorated with the rapid metabolic transformation of COL in vivo, which thus may be an effective detoxification pathway for COL poisoning.
The findings of the present study provided new insight into the molecular mechanism of COL poisoning, thus helpful for guiding reasonable application of this phytotoxin.
秋水仙碱(COL)是一种广为人知的植物源促有丝分裂毒素,已被广泛应用于治疗免疫系统疾病和各种癌症。然而,其临床应用因中毒事故频繁发生而受到严重限制,且COL中毒的机制尚不清楚。
本研究旨在通过对动物模型和临床病例进行非靶向代谢组学分析,揭示COL作为毒素的作用机制。
采用口服COL的KM小鼠建立中毒模型,采集血浆样本进行非靶向代谢组学分析。进行数据挖掘以筛选剂量依赖性差异和受干扰的代谢途径。进一步分析在治疗期间不同时间点从临床COL中毒患者采集的血样,以研究COL在体内代谢处置的时间变化,并验证小鼠实验结果。最后,通过酶联免疫吸附测定(ELISA)和蛋白质免疫印迹分析评估关键途径的表达。
组织学检查显示COL中毒对小鼠具有全身毒性。对模型小鼠和临床病例的血浆样本进行代谢物谱分析均显示,COL中毒可通过FXR/AMPK信号通路显著干扰体内氨基酸代谢和脂质代谢。对COL代谢过程的定量监测进一步表明,随着COL在体内的快速代谢转化,其毒性可得到极大改善,这可能是COL中毒的一种有效解毒途径。
本研究结果为COL中毒的分子机制提供了新的见解,有助于指导这种植物毒素的合理应用。